Inside the research

Fortive Corporation

FTV Research profile · latest available data

Price overview

$56.09

▲ +0.65 (+1.2%)

52w hi$64.01
52w lo$47.46
Vol1.70M
As of25 Sep 2026

The Verdict

Hold

Our score -0.10

Short-0.57
Medium+0.15
Long+0.35

computed 2026-09-27

Key fundamentals

Fortive Corporation

Technology · Scientific & Technical Instruments

Market cap$16.94B
Enterprise value$20.17B
Trailing P/E29.68x
Forward P/E17.27x
EV / EBITDA16.34x
P / S (ttm)3.96x
Profit margin12.4%
Return on equity7.3%
Revenue growth+7.9%
Earnings growth+4.0%
Debt / equity59.28

Layer Breakdown

LayerRawContribution
Fundamental+0.20
Sector+0.19
Technical-0.33
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

United States · www.fortive.com

Risk Metrics

Beta vs SPX0.90
Corr SPX0.55
Annual vol26.4%
Annual ret+2.2%
Sharpe0.08
Max DD-25.6%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$63.40
High / Low$73.00 / $51.00
Median$63.00
Analysts15
Strong Buy1
Buy2
Hold12
Sell1
Strong Sell1

Recent rating actions

2026-05-04Wells Fargo→ Equal-Weight
2026-05-04Truist Securities→ Hold
2026-05-01RBC Capital→ Sector Perform
2026-05-01Citigroup→ Neutral
2026-04-20Truist Securities→ Hold
2026-04-01Wells Fargo→ Equal-Weight

Material Events

DateEvent8-K
2026-07-29Earnings Release, Exhibitsread
2026-06-11Shareholder Voteread
2026-05-14Material Agreement, Material Obligation…read
2026-04-30Earnings Release, Exhibitsread
2026-03-20Material Agreement, Material Obligation…read
2026-02-04Earnings Release, Exhibitsread
2025-10-29Earnings Release, Exhibitsread
2025-10-16Officer / Director Changeread
2025-07-30Earnings Release, Exhibitsread
2025-06-30Material Agreement, Acquisition / Disposition…read
2025-06-10Earnings Release, Exhibitsread
2025-06-06Officer / Director Change, Shareholder Vote…read

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-10Underwood Peter CSVP - Chief Legal OfficerSell8.66K$533.49K
2026-07-02Soroye OlumidePresident & CEOWithheld for tax3.78K$236.63K
2026-07-02Lassiter Wright IIIL4$257
2026-06-09MITCHELL KATEGrant3.35K—
2026-06-09Moore Gregory J.Grant3.35K—

Flow & Concentration

Insider 180d net-$533.49K
Insider buys / sells0 / 1
Insider biasNeutral
13F holders8
Top-5 share97.5%
HHI4,830 (concentrated)

Top Holders

HolderValueShares
State Street Corp$832.87M13.62M
Capital Research / Capital World$259.73M4.25M
Renaissance Technologies$81.09M1.33M
AQR Capital Management$34.91M576.39K
Fidelity / FMR LLC$21.95M359.36K
Millennium Management$19.98M326.99K
Citadel Advisors$10.48M171.49K
T. Rowe Price Group$1.49M24.38M

As of 2026-06-30

Dividends

Yield (TTM)0.21%
$ / share (TTM)$0.12
5y CAGR+5.4%

Annual dividend per share

2021$0.21
2022$0.21
2023$0.22
2024$0.24
2025$0.24
2026$0.06

SEC Filings

DateFormDoc
2026-08-114view
2026-08-044view
2026-07-298-Kview
2026-07-2910-Qview
2026-07-074view
2026-07-074view
2026-07-074view
2026-07-074view
2026-07-074view
2026-07-074view
2026-06-2411-Kview
2026-06-114view
2026-06-114view
2026-06-114view
2026-06-114view

The Long Run

FY 2016–2025 · 10 years

LineLatestCAGRTrend
Revenue$1.02B-18.4%
Gross profit$641.50M-2.0%
Operating income$165.30M-6.5%
Net income$579.20M-33.1%
Cash from ops$1.35B+2.0%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$55.45$56.44$55.41$56.091.70M
Sep 24$56.14$56.28$55.32$55.442.21M
Sep 23$55.68$56.40$55.59$56.261.65M
Sep 22$55.81$56.11$55.32$55.951.66M
Sep 21$55.18$55.56$54.85$55.091.62M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →